LegitScript Certified
Important Safety Information. Prescription medications — including hormone therapy and GLP-1 medications — carry real risks that vary by individual, product, dose, and duration. Hormone therapy risks include cardiovascular events and breast cancer (in combination with progestins), among others. Use the lowest effective dose for the shortest duration consistent with treatment goals and patient risk. All treatment is subject to evaluation by a licensed clinician, who may determine a prescription is not appropriate; a prescription is not guaranteed. Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. This page is for informational purposes only and does not constitute medical advice. Individual results vary. Subscriptions renew automatically at the end of each plan period unless cancelled at least 72 hours before the renewal date. Report side effects to FDA MedWatch at fda.gov/safety/medwatch. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S; Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. HerEstrogen is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Brand-name medications are subject to manufacturer availability, clinician approval, and supply.